Chromosome-mediated multidrug resistance in salmonella enterica serovar typhi

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 721-723

  Chiou, Chien Shun ^a   Alam, Munirul ^b   Kuo, Jung Che ^a   Liu, Yen Yi ^a   Wang, Pei Jen ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; TRANSPOSON;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM ISOLATION; BANGLADESH; GENETIC RESISTANCE; GENOMIC ISLAND; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; TRANSPOSON; BACTERIAL GENE; DRUG EFFECTS; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR GENETICS; SALMONELLA ENTERICA SEROVAR TYPHI; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; BANGLADESH; CHROMOSOMES, BACTERIAL; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 84920194631     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04081-14     Document Type: Article

References (30)

1. Crump JA, Luby SP, Mintz ED. 2004. The global burden of typhoid fever. Bull World Health Organ 82:346-353.
2. Connor BA, Schwartz E. 2005. Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 5:623-628. http://dx.doi.org/10.1016/S1473-3099(05)70239-5.
3. Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J, Medalla F, Barzilay E, Joyce K, Barrett T, Mintz ED. 2009. Typhoid fever in the United States, 1999-2006. JAMA 302:859-865. http://dx.doi.org/10 .1001/jama.2009.1229.
4. Wu L-J, Chen W-C, Lin M-C, Yang S-Y. 2011. The epidemic and interventions in imported typhoid among Indonesian labors in 2009. Taiwan Epidemiol Bull 27:67-74.
5. Rowe B, Ward LR, Threlfall EJ. 1997. Multidrug-resistant Salmonella Typhi: a worldwide epidemic. Clin Infect Dis 24(Suppl 1):S106-S109. http://dx.doi.org/10.1093/clinids/24.Supplement-1.S106.
6. Holt KE, Phan MD, Baker S, Duy PT, Nga TV, Nair S, Turner AK, Walsh C, Fanning S, Farrell-Ward S, Dutta S, Kariuki S, Weill FX, Parkhill J, Dougan G, Wain J. 2011. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis 5:e1245. http://dx.doi.org/10.1371/journal.pntd .0001245.
7. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TT, Van Vinh Chau N, Tuan PQ, Page AL, Ochiai RL, Schultsz C, Wain J, Bhutta ZA, Parry CM, Bhattacharya SK, Dutta S, Agtini M, Dong B, Honghui Y, Anh DD, Canh do G, Naheed A, Albert MJ, Phetsouvanh R, Newton PN, Basnyat B, Arjyal A, La TT, Rang NN, Phuong le T, Van Be Bay P, von Seidlein L, Dougan G, Clemens JD, Vinh H, Hien TT, Chinh NT, Acosta CJ, Farrar J, Dolecek C. 2007. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 51:4315-4323. http://dx.doi.org/10.1128/AAC.00294-07.
8. Medalla F, Sjolund-Karlsson M, Shin S, Harvey E, Joyce K, Theobald L, Nygren BN, Pecic G, Gay K, Austin J, Stuart A, Blanton E, Mintz ED, Whichard JM, Barzilay EJ. 2011. Ciprofloxacin-resistant Salmonella enterica serotype Typhi, United States, 1999-2008. Emerg Infect Dis 17: 1095-1098. http://dx.doi.org/10.3201/eid/1706.100594.
9. Chiou C-S, Lauderdale T-L, Phung DC, Watanabe H, Kuo J-C, Wang P-J, Liu Y-Y, Liang S-Y, Chen P-C. 2014. Antimicrobial resistance in Salmonella enterica serovar Typhi from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother 58:6501-6507. http://dx .doi.org/10.1128/AAC.03608-14.
10. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, Le TA, Acosta CJ, Farrar J, Dougan G, Achtman M. 2006. Evolutionary history of Salmonella Typhi. Science 314:1301-1304. http://dx.doi.org/10 .1126/science.1134933.
11. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18:821-829. http://dx.doi .org/10.1101/gr.074492.107.
12. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410.
13. Holt KE, Thomson NR, Wain J, Phan MD, Nair S, Hasan R, Bhutta ZA, Quail MA, Norbertczak H, Walker D, Dougan G, Parkhill J. 2007.Multidrug-resistant Salmonella enterica serovar Paratyphi A harbors IncHI1 plasmids similar to those found in serovar Typhi. J Bacteriol 189: 4257-4264. http://dx.doi.org/10.1128/JB.00232-07.
14. Juhas M, van der Meer JR, Gaillard M, Harding RM, Hood DW, Crook DW. 2009. Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev 33:376-393. http://dx.doi.org/10 .1111/j.1574-6976.2008.00136.x.
15. Levings RS, Djordjevic SP, Hall RM. 2008. SGI2, a relative of Salmonella genomic island SGI1 with an independent origin. Antimicrob Agents Chemother 52:2529-2537. http://dx.doi.org/10.1128/AAC.00189-08
16. Mulvey MR, Boyd DA, Olson AB, Doublet B, Cloeckaert A. 2006. The genetics of Salmonella genomic island 1. Microbes Infect 8:1915-1922. http://dx.doi.org/10.1016/j.micinf.2005.12.028.
17. Moreno Switt AI, den Bakker HC, Cummings CA, Rodriguez-Rivera LD, Govoni G, Raneiri ML, Degoricija L, Brown S, Hoelzer K, Peters JE, Bolchacova E, Furtado MR, Wiedmann M. 2012. Identification and characterization of novel Salmonella mobile elements involved in the dissemination of genes linked to virulence and transmission. PLoS One 7:e41247. http://dx.doi.org/10.1371/journal.pone.0041247.
18. Boyd D, Peters GA, Cloeckaert A, Boumedine KS, Chaslus-Dancla E, Imberechts H, Mulvey MR. 2001. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol 183:5725-5732. http://dx.doi.org/10.1128/JB.183.19.5725-5732.2001.
19. Izumiya H, Sekizuka T, Nakaya H, Taguchi M, Oguchi A, Ichikawa N, Nishiko R, Yamazaki S, Fujita N, Watanabe H, Ohnishi M, Kuroda M.2011. Whole-genome analysis of Salmonella enterica serovar Typhimurium T000240 reveals the acquisition of a genomic island involved in multidrug resistance via IS1 derivatives on the chromosome. Antimicrob Agents Chemother 55:623-630. http://dx.doi.org/10.1128/AAC.01215-10.
20. Lucarelli C, Dionisi AM, Torpdahl M, Villa L, Graziani C, Hopkins K, Threlfall J, Caprioli A, Luzzi I. 2010. Evidence for a second genomic island conferring multidrug resistance in a clonal group of strains of Salmonella enterica serovar Typhimurium and its monophasic variant circulating in Italy, Denmark, and the United Kingdom. J Clin Microbiol 48: 2103-2109. http://dx.doi.org/10.1128/JCM.01371-09.
21. Shahada F, Sekizuka T, Kuroda M, Kusumoto M, Ohishi D, Matsumoto A, Okazaki H, Tanaka K, Uchida I, Izumiya H, Watanabe H, Tamamura Y, Iwata T, Akiba M. 2011. Characterization of Salmonella enterica serovar Typhimurium isolates harboring a chromosomally encoded CMY-2 beta-lactamase gene located on a multidrug resistance genomic island. Antimicrob Agents Chemother 55:4114-4121. http://dx.doi.org /10.1128/AAC.00560-11.
22. Ogunleye AO, Carlson SA. 2012. Emergence of an SGI1-bearing Salmonella enterica serotype Kentucky isolated from septic poultry in Nigeria. J Infect Dev Ctries 6:483-488. http://dx.doi.org/10.3855/jidc.1988.
23. Carlson SA, Sharma VK, McCuddin ZP, Rasmussen MA, Franklin SK.2007. Involvement of a Salmonella genomic island 1 gene in the rumen protozoan-mediated enhancement of invasion for multiple-antibioticresistant Salmonella enterica serovar Typhimurium. Infect Immun 75: 792-800. http://dx.doi.org/10.1128/IAI.00679-06.
24. Sahu SN, Anriany Y, Grim CJ, Kim S, Chang Z, Joseph SW, Cinar HN.2013. Identification of virulence properties in Salmonella Typhimurium DT104 using Caenorhabditis elegans. PLoS One 8:e76673. http://dx.doi .org/10.1371/journal.pone.0076673.
25. Threlfall EJ. 2000. Epidemic Salmonella typhimurium DT 104-a truly international multiresistant clone. J Antimicrob Chemother 46:7-10. http://dx.doi.org/10.1093/jac/46.1.7.
26. Helms M, Ethelberg S, Molbak K. 2005. International Salmonella Typhimurium DT104 infections, 1992-2001. Emerg Infect Dis 11:859-867. http://dx.doi.org/10.3201/eid1106.041017.
27. Kuo HC, Lauderdale TL, Lo DY, Chen CL, Chen PC, Liang SY, Kuo JC, Liao YS, Liao CH, Tsao CS, Chiou CS. 2014. An association of genotypes and antimicrobial resistance patterns among Salmonella isolates from pigs and humans in Taiwan. PLoS One 9:e95772. http://dx.doi.org/10.1371 /journal.pone.0095772.
28. Torpdahl M, Lauderdale TL, Liang SY, Li I, Wei SH, Chiou CS. 2013.Humanisolates of Salmonella enterica serovar Typhimurium from Taiwan displayed significantly higher levels of antimicrobial resistance than those from Denmark. Int J Food Microbiol 161:69-75. http://dx.doi.org/10 .1016/j.ijfoodmicro.2012.11.022.
29. Giraud E, Cloeckaert A, Baucheron S, Mouline C, Chaslus-Dancla E.2003. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 52:697-703. http://dx.doi.org/10 .1099/jmm.0.05178-0.
30. Baker S, Duy PT, Nga TV, Dung TT, Phat VV, Chau TT, Turner AK, Farrar J, Boni MF. 2013. Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure. eLife 2:e01229. http://dx.doi.org/10.7554/eLife.01229.